Gregor Diagnostics is thrilled to announce the addition of Dr. Michael Feloney, MD, FACS, to our Scientific Advisory Board!
Dr. Feloney is the Chairman of the Department of Urology at Creighton University School of Medicine in Omaha, Nebraska and is the co-founder and president of F&S Medical Solutions. He is a surgeon double boarded in Urology and Female Pelvic Medicine and Reconstructive Surgery. Dr. Feloney practices medicine within the CHI Health system in Omaha, Nebraska where he sees patients with a broad array of urological ailments including prostate cancer.
His insights into the patient experience and enthusiasm regarding Gregor's approach to prostate cancer screening make Dr. Feloney a great addition to Gregor's Scientific Advisory Board. We look forward to his continued support and collaboration as we develop our test.
Dr. Feloney joins an accomplished group physicians, researchers, and industry professionals guiding Gregor's scientific trajectory as we build our screening test for prostate cancer. Those current members include:
- Dr. David Jarrard, MD, - Urologic Oncologist at UW Health and Associate Director of the Carbone Cancer Center
- Dr. Jason Christiansen, PhD, - Chief Technology Officer at Boundless Bio
- Dr. Hon Leong, PhD, - Scientist at the Sunnybrook Research Institute and Professor at the University of Toronto
- Dr. Robert Wolfert, PhD, - Vice President of Research and Development Dynex Technologies